The prognostic value of detailed anatomic site and ultraviolet radiation (UVR) exposure patterns has not been fully determined in cutaneous melanoma. Thus, we reviewed medical records for detailed site in a population-based retrospective Swedish patient cohort diagnosed with primary invasive melanoma 1976-2003 (n 5 5,973). We followed the patients from date of diagnosis until death, emigration or December 31 st 2013, and evaluated melanoma-specific survival by subsite in a multivariable regression model adjusting for established prognostic factors. We found that melanoma on chronic UVR exposure sites (face, dorsum of hands; adjusted HR 0.6; CI 0.4-0.7) and moderately intermittent UVR sites (lateral arms, lower legs, dorsum of feet; HR 0.7; CI 0.6-0.8) were associated with a favorable prognosis compared with highly intermittent sites (chest, back, neck, shoulders and thighs). Further, melanoma on poorly visible skin sites upon self-examination (scalp, retroauricular area, back, posterior upper arms and thighs, buttocks, pubic area; HR 1.3; CI 1.1-1.5) had a worse prognosis than those on easily visible sites (face, chest, abdomen, anterior upper arms and thighs, lower arms and legs, dorsum of hands and feet, palms).
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Anatomic site according to the International Classification of Diseases (ICD)
1 is an established prognostic factor for localized cutaneous melanoma. [2] [3] [4] A poor prognosis has generally been reported among patients with melanoma on the trunk, 2,3 scalp and neck [5] [6] [7] as compared to the extremities and face, not explained by variation in other tumor characteristics. However, the ICD classification is strictly anatomic and does not account for exposure-or detection-related factors, such as ultraviolet radiation (UVR) exposure patterns or visibility upon skin self-examination (SSE).
The potential prognostic importance of detailed anatomic site beyond the ICD classification level has been investigated with conflicting results, perhaps due to variable patient inclusion, site definitions and/or small size (mean 1,470 patients, range 156-5,093), and varying ability to adjust for confounding factors. [8] [9] [10] [11] [12] [13] [14] [15] Our group has previously identified the middle and lower back, and the supramammary and mammary area as negative prognostic sites in a Swedish populationbased regional cohort of 1,891 patients, but had numbers of tumors too low to investigate several other sites. 9 We have not found studies comparing melanoma sites classified by different patterns of UVR exposure with respect to patient survival. However, since the trunk and extremities are generally considered to mirror a crudely intermittent-, and the face a crudely chronic UVR exposure, differences in UVR exposure patterns may contribute to the prognostic differences seen between these body sites. This hypothesis is only partially supported by previous nonsite related studies implying inverse or neutral associations between measures of intermittent [16] [17] [18] [19] as well as chronic 16, 20 UVR exposure and mortality. We combined an extensive medical records review to assess detailed location of the primary tumor and a tailored anatomic software 21 to investigate the prognostic differences of detailed anatomic site in an expanded population-based cohort of 6,295 melanoma patients. Specifically, we hypothesized that patients with tumors on intermittent UVR exposure sites might have a reduced survival as compared to those with primary site on chronic UVR exposure sites. Since anatomic location by UVR exposure patterns could be expected to correlate with visibility upon SSE, we also investigated the potential prognostic impact of poorly versus easily visible skin sites of melanoma. Thirdly, we assessed whether an anatomic classification more detailed than the four major sites (head-neck, trunk, arms and legs) commonly used in survival analyses improves the accuracy of prognostic prediction.
Material and Methods

Setting and study population
The Swedish healthcare system is decentralized and publicly funded, enabling equal access to specialized care for malignant disease for all residents. Out of 6,943 eligible patients diagnosed with invasive melanoma since the start of the population-based Regional Melanoma Register in Stockholm and Gotland (RMR; coverage 98.6% during the study period) in 1976 until 2003, 22 5,973 patients with a single localized invasive melanoma remained in the study after exclusions of patients with metastatic disease at diagnosis (n 5 380), multiple invasive lesions (n 5 187) and/or missing data for these variables (n 5 78 and n 5 3, respectively) or detailed antomic site (n 5 322). Patients with a single invasive lesion and additional in situ lesions remained in the study while the in situ lesions were excluded. The study was approved by the regional ethical review board in Stockholm, Sweden (2007/ 1396-32 and 2014/2007-32) . Informed consent was not mandatory, in line with the ethical approval.
Data sources and variables
Patient characteristics (sex, age), date of melanoma diagnosis and established tumor characteristics (ICD code, thickness, ulceration, invasion level, histological type) were derived from the RMR, whereas the date and main cause of death were collected from the national Cause-of-Death Register. From 1975 to 2005, the coverage of death certificates was on average 99.7%, and the annual proportion of insufficiently specified causes of death (as defined by the WHO) ranged from 0.5 to 2.6%. 23 Date of emigration was collected from the Total Population Register. 24 We followed the patients from date of diagnosis to death (melanoma-specific or othercause), emigration or December 31 st , 2013, whichever came first. Death was classified as due to melanoma when melanoma was reported as the main underlying cause of death.
Detailed anatomic location was classified through review of medical records for each patient (available photographies, sketches and/or text descriptions in patient records), and entered on a three-dimensional virtual patient "doll" (SkinTracV C , formerly EssDollV C ) together with the estimated precision achieved (i.e., within a 0-2.5, 2.5-5, 5-10, 10-15 or >15 cm radius). 21 If a more precise description of site than the ICD code was not available, SkinTracV C data was classified as missing and the patient was excluded. The majority (74%) of the tumor sites were recorded with a precision of 0-2.5 or 2.5-5 cm, and only 4% were recorded with a precision of >15 cm.
UVR exposure model
In SkinTracV C , we applied a modified UVR exposure model developed by Augustsson 25 and modified by Gordon 26 et al. that classifies the body surface into five categories based on the predominant pattern of UVR exposure (see Supporting Information Fig. S1 ). 25, 26 Chronic UVR exposure sites (face, dorsum of hands) are exposed to UVR on a daily basis the larger part of the year, while moderately intermittent sites (lateral arms, lower legs, dorsum of feet) are characterised by a more seasonal exposure, and highly intermittent sites (chest, back, neck, shoulders and thighs) are exposed mainly during active sunbathing or outdoor sports. Sites classified as rare (medial arms, lower abdomen and buttocks) or other (scalp, palms and soles) are mostly unexposed or covered from direct sunlight.
Skin visibility model
We also created a novel skin visibility model in which the face, chest (including anterior neck and shoulders), abdomen, anterior upper arms and thighs, lower arms and legs, dorsum of hands and feet and palms were classified as easily visible What's new? Patients with melanoma on the trunk, scalp and neck generally have poorer prognosis than those whose cancers appear on the extremities or face. To further refine predictions, these authors further classified anatomic locales both by presumed UVR exposure and visibility upon skin self-examination. Melanomas on regions receiving chronic and moderately intermittent UVR exposure had better outcomes than those in highly intermittent exposure sites. A favorable outcome also correlated with cancers in skin sites that were easily, compared to poorly, visible to the patient. sites upon SSE. Conversely, the scalp, retroauricular area, back (including posterior neck and shoulders), posterior upper arms and thighs, buttocks and pubic area were classified as poorly visible sites (see Supporting Information Fig.  S2 ).
Anatomic subsite model
To investigate potential prognostic differences within major anatomic sites, we identified 24 subsites (in line with the model by Gillgren et al.) 9 within five major anatomic sites (see Supporting Information Fig. S3 , with subsites no. 
Statistical analysis
We used Cox proportional hazards regression for modeling time to melanoma-specific death. Two main statistical models were used for confounder adjustment: (i) a partially adjusted model that included sex, age and calendar year of diagnosis and (ii) a fully adjusted model that also included tumor characteristics (thickness, ulceration and invasion level). Histological type was not added to the final model since the variable was not significantly associated with melanoma-specific death. In order to improve the ability to adjust for confounding, all continuous variables were evaluated for non-linearity using penalized splines. If the model containing a penalized spline indicated a significant improvement, that is, a likelihood ratio (LR) test p-Value of <0.05, the spline was retained.
The proportional hazards assumption was evaluated using the Grambsch and Therneau method based on weighted residuals. 27 If the overall model indicated nonproportionality, we included interaction terms between follow-up time (6 month intervals) and the variables (age, ulceration) where the proportional hazards assumption was not satisfied.
To test prognostic heterogeneity within the major anatomic sites, we first estimated one regression model where the major sites were represented by one regression parameter each (except the most prevalent site which was set as the reference category), and then a set of models where the major site (one per model) had been replaced by its subsites. To compare the nested models for each major site in turn, we used a LR test to test the hypothesis that at least one regression parameter corresponding to the subsites (the full model) were statistically different from the parameter representing the major site (the submodel), as recommended by Faraway. 28 p-Values <0.05 were interpreted as statistically significant. These test were first carried out in models that also included the nontumor specific variables (partially adjusted), and subsequently in models containing all variables (fully adjusted models).
For plotting adjusted survival curves, we used the Royston and Parmar's extension to the Cox model. 29 It extends the model by explicitly estimating the cumulative hazard function using natural cubic splines. This allows for model-based predictions of covariate-specific survival functions and is thereby suitable for providing an adjusted alternative to KaplanMeier plots. Based on the fully adjusted Cox regression model, we predicted survival functions for each level of exposure (chronic, moderately-and highly intermittent UVR exposure sites, and easily and poorly visible sites) where the adjustment variables were fixed at median values of age, calendar year of diagnosis and tumor thickness, female sex, Clark invasion level II and absence of ulceration.
Interactions between UVR exposure-and visibility sites were tested by comparing nested models together using LR tests. The UVR exposure model was also stratified by sex. Distributions between UVR exposure sites and visibility sites were investigated using Fisher's exact test for categorical values and two-sample Wilcoxon test for continuous variables.
Sensitivity analyses were performed to investigate (i) including both underlying and contributing causes of death as melanoma-specific and (ii) excluding cases with acral lentiginous melanoma. 30 To provide estimates of melanomaspecific survival in the presence of competing causes of death, supplemental competing risk analyses using Fine and Gray models were also carried out. 31 All analyses were performed with R 3.3.2, using the survival-package (v. 
Results
In the final cohort of 5,973 melanoma patients, there were slightly more women than men (Table 1) . Median age at diagnosis was 58 years (women: 55 years, men: 60 years). The most common melanoma location among women was on the legs (39.4%), followed by the trunk (including shoulders, 32.6%). The dominating location for men was on the trunk (60.8%), whereas the legs (13.6%), arms (13.0%) and head-neck (12.6%) were less prevalent. Age at diagnosis differed by site and patients with head-neck melanoma were the oldest at diagnosis (median 70.1 years), and those with melanoma on the legs were the youngest (54.8 years). The patients were followed for a median of 14 years, ranging from 0 to 38 years. During the study period, 2,919 (48.9%) patients died. Overall, 906 deaths (31.0%) were classified as melanoma-specific, the majority of which (54.0%) occurred in patients with trunk melanoma. One hundred and twentyfive patients were lost to follow-up due to emigration. Most melanomas (60.3%) occurred on highly intermittent UVR exposure sites (Table 2 ). These sites also showed a higher proportion of melanoma-specific death (16.0%) than moderately intermittent (12.9%) and chronic UVR exposure (12.1%) sites. The proportion of melanoma-specific deaths was also higher among patients with melanoma on poorly visible (17.5%) than easily visible (13.3%) sites upon SSE. Melanomas on highly intermittent UVR exposure sites were thinner, less ulcerated and less invasive than those on moderately exposed and chronic sites (see Supporting Information Table S1 ), whereas tumors on poorly visible sites did not differ from those on easily visible sites with regard to tumor thickness or presence of ulceration (see Supporting Information Table S2 ).
In the fully adjusted Cox proportional hazards model, the risk of melanoma-specific death was significantly lower among patients with melanoma on chronic UVR exposure sites (adjusted HR 0.6; CI 0.4-0.7, p < 0.0001) and moderately intermittent sites (HR 0.7; CI 0.6-0.8, p 5 0.0001) compared with highly intermittent sites (Table 3) , with similar associations between the sexes (see Supporting Information Table  S3 ). Survival proportions adjusted to median values of age, year of diagnosis and tumor thickness, female sex, Clark invasion level II and absence of ulceration are shown in Figure 1 . Competing risk regression models (where death due to other causes was included as a competing event) that were further stratified by sex, and sensitivity analyses that used both the underlying (n 5 906) and contributing (n 5 143) causes of death to define melanoma-specific death provided similar results for intermittent and chronic sites (see Supporting Information Tables S4-S6 ). Exclusion of acral lentiginous melanomas did not change the results (see Supporting Information Table S7 ). When analysing risk of overall death, estimates moved towards unity (see Supporting Information Table S8 ).
Patients with melanomas on poorly visible sites upon SSE were at increased risk of melanoma-specific death (HR 1.3; CI 1.1-1.5) compared with those with tumors located on easily visible sites (Table 3 , Fig. 2 ). There was no evidence of interaction between UVR exposure pattern and skin visibility in risk of melanoma-specific death (p 5 0.6). Analyses of UVR exposure pattern and risk of melanoma-specific death separately among patients with only easily visible tumors and among those with poorly visible tumors revealed similar results in both groups as in the overall analyses (see Supporting Information Table S9 ). The associations between visibility and melanoma-specific death were somewhat weakened when stratified by subgroups of UVR exposure patterns.
Divided by major anatomic site, melanomas on the arms (adjusted HR 0.5, CI 0.4-0.6), legs (HR 0.6, CI 0.5-0.7), head-neck (HR 0.6, 95% CI 0.5-0.8) and acral (HR 0.7, CI 0.4-1.0) sites were associated with a lower risk of melanomaspecific death compared with the trunk (Table 3) . Prognostic heterogeneity was observed within the head-neck area, with a worse prognosis for the neck (HR 1.7, CI 1.0-3.0, p 5 0.035) compared to the face and ears. Within acral sites, a better prognosis was shown for subungual areas (HR 0.4, CI 0.2-1.0, p 5 0.040) compared with the palms and soles. However, the numbers of patients and deaths from melanoma on the neck or the subungual sites were relatively small. More detailed anatomic subdivision of the trunk and extremities did not add prognostic value (data not shown).
Discussion
In this very large population based cohort using detailed classification of anatomic site, we found that patients with melanoma located on highly intermittent UVR exposure sites had a reduced melanoma-specific survival compared with patients with melanomas located on sites characterized by chronic or moderately intermittent UVR exposure. This novel finding was not explained by differences in established tumor characteristics or visibility upon SSE. In addition, our results indicate that patients with melanoma on poorly visible skin sites upon SSE fared worse than those with melanoma on easily visible sites, independently of other investigated prognostic factors. We also observed a prognostic heterogeneity within 3 Trunk excluding scrotum (C43.5). 4 Upper extremity including shoulder (C43.6). 5 Lower extremity including hip (C43.7). 6 SSM: superficial spreading melanoma; LMM: Lentigo maligna melanoma; NM: nodular melanoma; ALM, Acral lentiginous melanoma. 1 Number of individuals who died/number of individuals at risk. 2 Chest (including anterior neck and shoulders), back (including posterior neck and shoulders), thighs (anterior) and thighs (posterior). 3 Arms (lateral), lower legs (anterior), lower legs (posterior) and dorsum of feet. 4 Face, dorsum of hands. 5 Arms (medial), lower abdomen, buttocks. 6 Scalp, palms, soles. 7 Face, chest (including anterior neck and shoulders), abdomen, anterior upper arms and thighs, lower arms and legs, dorsum of hands and feet, palms. 8 Scalp, retroauricular area, back (including posterior neck and shoulders), posterior upper arms and thighs, buttocks, pubic area. 9 Including lip and eyelid.
head-neck and acral sites, but did not find evidence of additional prognostic value from further anatomic subdivision of the extremities, or the trunk. Only a few previous studies have specifically aimed to evaluate UVR exposure pattern and survival among melanoma patients, and the definition of UVR exposure in the majority of these was based on self-reported personal behavior in the sun and not assigned by site. A population based study by Berwick et al. [n 5 528] detected an independent inverse association between the presence (compared with absence) of solar elastosis and disease-specific mortality [HR 0.4, 95% CI 0.2-0.8; n (deaths) 5 21] . 16 Since solar elastosis is regarded as a marker of chronic UVR exposure, the results support chronic UVR exposure as a protective prognostic factor, in line with our findings. A protective tendency (p values for trend 5 0.07) was also observed by Heenan et al. . 16 A subsequent large multicenter cohort with detailed sun exposure data [n 5 3,578; average follow-up 7.4 years] by the GEM study group found a reduced melanoma-specific mortality associated with sunburn within ten years of diagnosis [HR 0.27, 95% CI 0.09-0.85; n (deaths) 5 4] but no significant associations for several other measures of intermittent UVR exposure, or solar elastosis in adjusted models. 17 Further, nonsignificant inverse associations were reported by Rosso et al. 1 Adjusted for sex, age and year of diagnosis. 2 Adjusted for sex, age, year of diagnosis, tumor thickness, ulceration and Clark invasion level. 3 Subsites within major sites other than head-neck and acral are not shown due to lack of evidence of heterogeneity.
thickness, anatomic site and histology. 18 The findings above contrast with our results but have several weaknesses. Even the larger cohort by Berwick et al. was just over half the size of ours and had a relatively high proportion of missing data for several UVR exposure variables (e.g., 22% for solar elastosis) and lacked adjustment for tumor characteristics other than site. Possible mechanisms behind associations between UVR exposure and survival remain speculative. Increased production of vitamin D, nitric oxide 19 and melanin, and/or altered damage-repair mechanisms of DNA 16, 32 have been proposed as mechanisms behind a protective association, and might contribute to the favorable survival we detected among patients with melanoma on chronic UVR exposure sites. Conceivable mechanisms behind an adverse association for intermittent UVR exposure are largely unexplored, but given that BRAF mutations have been linked to intermittent UVR exposure 33 and the related factor 34 sunburn 35 as well as (variably to) reduced patient survival, 36 the role of BRAF as a potential mediator may warrant future investigation.
Although the scientific evidence of a survival benefit from SSE 37 and the related measure of melanoma screening 38 is insufficient, Berwick et al. have shown that patients who reported "skin awareness" before their melanoma diagnosis fared better [HR 0.5, 95% CI 0.3-0.9; n (deaths) 5 21] than those who did not, after adjustment for confounders. 16 A worse prognosis among patients diagnosed with melanoma on poorly visible skin sites upon SSE could be biologically explained by an aggregation of other unfavorable prognostic factors associated with a more advanced localized disease at diagnosis. The fact that no such differences in tumor characteristics were seen between poorly and easily visible skin sites in our study, and that poor skin visibility remained a significant negative prognostic factor even after adjustment for established prognostic factors suggests involvement of additional biological mechanisms. Although the results seemed partially explained by differences in UVR patterns, they are nevertheless clinically relevant and highlight the need of increased attention to these sites. Over the years, several anatomic subsite classifications have been proposed to predict prognosis. However, limitations have included low statistical power and/or low reproducibility. Two of the most studied are the BANS and TANS classifications. The BANS [(upper) back, (posterior) arms, (posterior) neck and (posterior) scalp] sites were identified as negative prognostic sites for stage I melanoma in the original study by Dal et al. 15 and a meta-analysis 12 but not in others 11, 13, 14 . The TANS [back and breast (thorax), upper arm, neck, and scalp] sites have been suggested as adverse prognostic sites in a study by Garbe et al. 10 In a previous study from our group, we identified independent negative prognostic subsites on the trunk [the middle and lower back, supramammary and mammary sites 9 , and the upper back 8 ] that overlap with BANS/TANS sites. Yet, in the present larger study we found no evidence of significant prognostic heterogeneity within the trunk or extremities. Nevertheless, we note that the proportions of melanoma-specific death for patients with trunk melanoma were in fact higher on the thorax and back (anatomic subsites no.1-4; 17.1-19.8%) than on the abdomen and lower trunk (subsites no. 5-7; 13.4-14.5%).
The rather low HR (0.6, 95% CI 0.5-0.8) of melanomaspecific death for head-neck versus trunk sites is not surprising given the high proportion of face and ear melanomas (n 5 549) relative to scalp (n 5 44) and neck (n 5 93) melanomas among head-neck patients. Among face and ear melanomas, the generally favorable group of face melanomas comprises 83% (n 5 458).
The main strengths of this study is the population-based inclusion of a large number of patients together with the quality of the data on detailed anatomic site, collected through a comprehensive review of medical records for each patient, ensuring high validity of the site assignment and a high statistical precision. In addition, we used high-coverage regional and national registries with prospectively collected data on tumor characteristics and had virtually no loss to follow-up.
The use of anatomic site as a proxy for UVR exposure pattern entails the possibility of misclassification bias, and the lack of information on individual behavior and protective measures remains a limitation of the study. Ideally, UVR exposure would be measured using a continuous UVR dosimetry over decades for each patient but this is for obvious reasons not a feasible option. The potential for misclassification is also evident for the visibility and anatomic subsite models due to the retrospective study design, but is likely to be non-differential. In addition, we cannot exclude the occurrence of some misclassification of cause of death. Further, sentinel node biopsy status 39 was not available from the RMR for the study period and might contribute to residual confounding, as could other factors such as socioeconomic status, 40 cohabitation 41 and comorbidities. In conclusion, detailed anatomic classification based on presumed UVR exposure sites as well as skin visibility upon SSE correlated significantly with melanoma survival, independently of established tumor characteristics. These results reinforce the importance of public health efforts to reduce intermittent UVR exposure among the public, yet considering the potentially dual effects of UVR exposure.
